Identification of a Disease-Defining Gene Fusion in Epithelioid HemangioendotheliomaMunir R. Tanas, Brian P. Rubin, Andrea Sboner et al.|Science Translational Medicine|2011Cited by 401
Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor SensitivityIlirjana Bajrami, Alan Ashworth, Farah Rehman et al.|Cancer Research|2013Cited by 367